Astellas Venture Management
AV
AS

Astellas Venture Management

Measured by AhrefsDR25 out of 100, Below median. Ahrefs DR. Open the scores section.Ahrefs DR: 25/100. Below median. Measured by Ahrefs. Median 44.

2005Corporate Venture Capital3 portfolioUnited States

About

AVM is the wholly-owned venture capital organization within Astellas, dedicated to supporting pre-clinical, cutting-edge science that can bring VALUE to patients. For over 15 years, AVM has provided equity investments to private, early-stage companies developing therapeutic programs and platform technologies, helping them to advance their innovations faster. AVM is a strategic investor, making investments in science that will enhance the current Astellas R&D pipeline or that could catalyze new directions in discovery research.

Key facts

Website
astellasventure.com
Type
Corporate Venture Capital
Headquarters
United States
Portfolio companies
3
Stages
Pre-Seed
Series C
Cheque size
$5M to $46M
Sector focus
Life Sciences
Digital Twin
Therapeutics
Genetics

Recent investments

Recent funding rounds Astellas Venture Management took part in
DateCompanyRoundAmount
3 Sept 2024Somite.aiPre-Seed$5M
28 Oct 2013CrescendoUndisclosed round$18M

Test your Ahrefs DR

The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.

Write the first review

Frequently asked

What companies has Astellas Venture Management invested in?

Astellas Venture Management has invested in Somite.ai, Crescendo, Casma Therapeutics.

SEC filings, insider activity, nonprofit links and pay benchmarks for Astellas Venture Management: